Intelligent Cardiac Arrhythmia Treatment System

Publication ID: 24-11857380_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Cardiac Arrhythmia Treatment System,” Published Technical Disclosure No. 24-11857380_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857380_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,380.

Summary of the Inventive Concept

An innovative cardiac arrhythmia treatment system integrating AI, IoT, blockchain, and machine learning to provide personalized therapy, real-time arrhythmia detection, and secure data storage.

Background and Problem Solved

The original patent described a cardiac arrhythmia treatment device and delivery method, but it lacked the capabilities to adapt to individual patients' needs, provide real-time monitoring, and ensure secure data management. The new inventive concept addresses these limitations by incorporating cutting-edge technologies to create a more effective and efficient treatment system.

Detailed Description of the Inventive Concept

The system consists of a pulse generator, one or more leads, and a blockchain-based data storage unit for secure patient health data storage and treatment outcome tracking. The system utilizes machine learning algorithms to analyze patient data from the implantable cardiac device and generates a customized treatment plan. Additionally, the system integrates artificial intelligence for real-time arrhythmia detection and prediction, automatically adjusting pacing parameters to prevent arrhythmia onset. The system also includes a wearable device for monitoring cardiac health, comprising a sensor for detecting cardiac arrhythmias and a communication module for transmitting data to a remote server for analysis and feedback. Furthermore, the system optimizes cardiac resynchronization therapy using IoT connectivity to collect data from multiple implantable devices and a cloud-based server for data analysis and therapy optimization.

Novelty and Inventive Step

The new claims introduce the innovative combination of AI, IoT, blockchain, and machine learning technologies with the original cardiac arrhythmia treatment device and delivery method, providing a synergistic system that is more effective, efficient, and secure than the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include varying the type of AI algorithm used, incorporating additional sensors or data sources, or utilizing different blockchain architectures. Variations could also include integrating the system with other medical devices or electronic health records.

Potential Commercial Applications and Market

The Intelligent Cardiac Arrhythmia Treatment System has significant commercial potential in the medical device industry, particularly in the areas of cardiac care and personalized medicine. The system's ability to provide real-time monitoring, secure data storage, and personalized therapy makes it an attractive solution for hospitals, clinics, and patients.

CPC Classifications

SectionClassGroup
A A61 A61B90/39
A A61 A61B90/02
A A61 A61N1/0504
A A61 A61N1/0563
A A61 A61N1/0587
A A61 A61N1/362
A A61 A61N1/3621
A A61 A61N1/36521
A A61 A61N1/36542
A A61 A61N1/36557
A A61 A61N1/3787
A A61 A61N1/37217
A A61 A61N1/37264
A A61 A61N1/3956
A A61 A61B2090/3966
A A61 A61B2090/3983
A A61 A61N1/059
A A61 A61N1/3752

Field of Art

Medical Device Technology, specifically Cardiac Rhythm Management Systems, involving implantable medical devices, signal processing, and advanced medical electronics

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in cardiac device design, electrical engineering background, advanced knowledge of medical signal processing, and familiarity with emerging digital health technologies

Obviousness Rationale

A PHOSITA would recognize that integrating digital technologies like AI, machine learning, and blockchain into existing cardiac rhythm management systems represents a predictable technological evolution. The source patent establishes a foundational cardiac device architecture that naturally invites enhancement through contemporary digital monitoring and data management techniques. The proposed variations represent logical extensions of existing medical device technological trends, utilizing well-understood integration strategies.

Obvious Combinations & Variations

Source Patent Element
Cardiac pulse generator with electrical pulse transmission capabilities
PTD Variation
Adding machine learning algorithms for adaptive pulse parameter optimization
Obviousness Reasoning
Predictable application of known machine learning techniques to improve device performance, representing a standard design optimization approach in medical device engineering
Source Patent Element
Implantable cardiac lead for therapeutic electrical pulse delivery
PTD Variation
Incorporating IoT connectivity for remote monitoring and data transmission
Obviousness Reasoning
Well-established trend in medical device design to enable remote patient monitoring, using standard communication protocols and sensor integration techniques
Source Patent Element
Cardiac arrhythmia treatment method involving pulse generation
PTD Variation
Implementing blockchain-based secure data storage for patient treatment records
Obviousness Reasoning
Known cybersecurity technique applied to medical device data management, representing a standard approach to enhancing patient data protection
Source Patent Element
Intercostal lead placement method for cardiac therapy
PTD Variation
Adding AI-driven real-time arrhythmia detection and predictive intervention
Obviousness Reasoning
Logical extension of existing diagnostic capabilities using contemporary artificial intelligence pattern recognition techniques
Source Patent Element
Cardiac pulse generator with therapeutic electrical pulse capabilities
PTD Variation
Creating companion wearable device for continuous cardiac monitoring
Obviousness Reasoning
Predictable market-driven innovation extending device functionality through complementary monitoring technology
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857380 and the technological context of cardiac rhythm management systems, the proposed technical variations represent obvious modifications that would be readily conceived by a person having ordinary skill in the art, thereby establishing prior art that would render substantially similar claimed innovations non-patentable under standard obviousness analysis.

Original Patent Information

Patent NumberUS 11,857,380
TitleCardiac arrhythmia treatment devices and delivery
Assignee(s)AtaCor Medical, Inc.